PL2225261T3 - Inhibitory boropeptydowe enteropeptydaz i ich zastosowania w leczeniu otyłości, nadwagi i/lub chorób związanych z nieprawidłowym metabolizmem tłuszczów - Google Patents
Inhibitory boropeptydowe enteropeptydaz i ich zastosowania w leczeniu otyłości, nadwagi i/lub chorób związanych z nieprawidłowym metabolizmem tłuszczówInfo
- Publication number
- PL2225261T3 PL2225261T3 PL08855879.6T PL08855879T PL2225261T3 PL 2225261 T3 PL2225261 T3 PL 2225261T3 PL 08855879 T PL08855879 T PL 08855879T PL 2225261 T3 PL2225261 T3 PL 2225261T3
- Authority
- PL
- Poland
- Prior art keywords
- enteropeptidase
- overweight
- obesity
- treatment
- diseases associated
- Prior art date
Links
- 102100029727 Enteropeptidase Human genes 0.000 title 1
- 108010013369 Enteropeptidase Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 title 1
- 206010033307 Overweight Diseases 0.000 title 1
- 230000002159 abnormal effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99673207P | 2007-12-03 | 2007-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2225261T3 true PL2225261T3 (pl) | 2016-09-30 |
Family
ID=40404110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08855879.6T PL2225261T3 (pl) | 2007-12-03 | 2008-12-03 | Inhibitory boropeptydowe enteropeptydaz i ich zastosowania w leczeniu otyłości, nadwagi i/lub chorób związanych z nieprawidłowym metabolizmem tłuszczów |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100311690A1 (pl) |
| EP (1) | EP2225261B1 (pl) |
| CA (1) | CA2707549A1 (pl) |
| DK (1) | DK2225261T3 (pl) |
| ES (1) | ES2575131T3 (pl) |
| HR (1) | HRP20160569T1 (pl) |
| HU (1) | HUE028064T2 (pl) |
| PL (1) | PL2225261T3 (pl) |
| PT (1) | PT2225261E (pl) |
| SI (1) | SI2225261T1 (pl) |
| WO (1) | WO2009071601A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011071048A1 (ja) | 2009-12-07 | 2011-06-16 | 味の素株式会社 | ヘテロアリールカルボン酸エステル誘導体 |
| EP2725016B1 (en) | 2011-06-07 | 2016-12-21 | EA Pharma Co., Ltd. | Heterocyclic carboxylic acid ester derivative |
| JP6285917B2 (ja) | 2012-05-22 | 2018-02-28 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | 反応性代謝物質のスクリーニングのための捕獲剤 |
| US9024044B2 (en) | 2012-06-14 | 2015-05-05 | Ajinomoto Co., Inc. | Heteroarylcarboxylic acid ester derivative |
| AU2014230583B2 (en) | 2013-03-13 | 2017-09-28 | Takeda Pharmaceutical Company Limited | Guanidinobenzoic acid ester compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| WO2016100555A1 (en) * | 2014-12-18 | 2016-06-23 | Inception 4, Inc. | Boronic acid derivatives and uses thereof |
| US9975903B2 (en) | 2014-12-26 | 2018-05-22 | Takeda Pharmaceutical Company Limited | Condensed heterocyclic compound |
| CN107208052A (zh) | 2015-01-15 | 2017-09-26 | 国立大学法人大阪大学 | 由多能干细胞向角膜上皮细胞的分化诱导 |
| EP3275874B1 (en) | 2015-03-27 | 2019-10-30 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| HUE064412T2 (hu) | 2016-06-21 | 2024-03-28 | Orion Ophthalmology LLC | Heterociklusos prolinamid-származékok |
| JP7164521B2 (ja) | 2016-06-21 | 2022-11-01 | オリオン・オフサルモロジー・エルエルシー | 炭素環式プロリンアミド誘導体 |
| CN111542511A (zh) | 2017-11-02 | 2020-08-14 | 宇部兴产株式会社 | 蛋白分解酶的双头型抑制剂 |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| US20220281866A1 (en) | 2019-07-19 | 2022-09-08 | Janssen Pharmaceutica Nv | 5,8-disubstituted-[1,2,4]triazolo[1,5-a]pyridinyl and 5,8-disubstituted-imidazo[1,2-a]pyridine derivatives useful as inhibitors of enteropeptidase |
| CN115252758A (zh) * | 2022-08-16 | 2022-11-01 | 中国科学院南海海洋研究所 | 线性小分子肽类似物在制备抗肥胖和降糖药物中应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867539A (en) | 1973-04-27 | 1975-02-18 | Us Health | Method of producing anorexia as a treatment for obesity |
| US4446138A (en) | 1982-02-10 | 1984-05-01 | Pack Howard M | Method and composition for reducing weight |
| US4588724A (en) | 1982-12-10 | 1986-05-13 | Greenway Frank L Iii | Treatment for selective reduction of regional fat deposits |
| GB8430581D0 (en) | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| US5019594A (en) | 1989-11-28 | 1991-05-28 | Interneuron Pharmaceuticals, Inc. | Method for decreasing appetite |
| US5300298A (en) | 1992-05-06 | 1994-04-05 | The Pennsylvania Research Corporation | Methods of treating obesity with purine related compounds |
| US5573774A (en) | 1993-02-02 | 1996-11-12 | Keenan; Robert M. | Nicotine metabolites, nicotine dependence and human body weight |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| US5578613A (en) | 1993-12-21 | 1996-11-26 | Eli Lilly And Company | Methods for inhibiting weight gain or inducing weight loss |
| US5403851A (en) | 1994-04-05 | 1995-04-04 | Interneuron Pharmaceuticals, Inc. | Substituted tryptamines, phenalkylamines and related compounds |
| US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| SE9403861D0 (sv) | 1994-11-09 | 1994-11-09 | Astra Ab | Novel medicinal use |
| FR2745288B1 (fr) * | 1996-02-27 | 1998-04-17 | Adir | Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| NZ335162A (en) | 1996-11-27 | 2000-01-28 | Pfizer | Apo b-secretion/mtp inhibitory amides |
| CA2325358C (en) | 1999-11-10 | 2005-08-02 | Pfizer Products Inc. | 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| CA2588087A1 (en) * | 2004-11-15 | 2006-05-18 | Obe Therapy Biotechnology S.A.S. | Methods of reducing body fat |
-
2008
- 2008-12-03 ES ES08855879.6T patent/ES2575131T3/es active Active
- 2008-12-03 WO PCT/EP2008/066740 patent/WO2009071601A1/en not_active Ceased
- 2008-12-03 EP EP08855879.6A patent/EP2225261B1/en not_active Not-in-force
- 2008-12-03 HU HUE08855879A patent/HUE028064T2/en unknown
- 2008-12-03 HR HRP20160569TT patent/HRP20160569T1/hr unknown
- 2008-12-03 CA CA2707549A patent/CA2707549A1/en not_active Abandoned
- 2008-12-03 DK DK08855879.6T patent/DK2225261T3/en active
- 2008-12-03 SI SI200831618A patent/SI2225261T1/sl unknown
- 2008-12-03 US US12/746,105 patent/US20100311690A1/en not_active Abandoned
- 2008-12-03 PL PL08855879.6T patent/PL2225261T3/pl unknown
- 2008-12-03 PT PT08855879T patent/PT2225261E/pt unknown
-
2013
- 2013-12-16 US US14/107,855 patent/US9481709B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT2225261E (pt) | 2016-06-09 |
| ES2575131T3 (es) | 2016-06-24 |
| EP2225261B1 (en) | 2016-03-09 |
| DK2225261T3 (en) | 2016-06-06 |
| EP2225261A1 (en) | 2010-09-08 |
| SI2225261T1 (sl) | 2016-07-29 |
| US9481709B2 (en) | 2016-11-01 |
| WO2009071601A1 (en) | 2009-06-11 |
| US20140187479A1 (en) | 2014-07-03 |
| HUE028064T2 (en) | 2016-11-28 |
| US20100311690A1 (en) | 2010-12-09 |
| CA2707549A1 (en) | 2009-06-11 |
| HRP20160569T1 (hr) | 2016-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2225261T1 (sl) | Boropeptidni inhibitorji enteropeptidaze in njihove uporabe pri zdravljenju debelosti, prekomerne teže in/ali bolezni, povezanih z nenormalno presnovo maščob | |
| EP2150308A4 (en) | ANALYSIS AND REGULATION OF FOODSTUFFS | |
| ZA200905101B (en) | Diagosis and treatment of preeclampsia | |
| PL1945235T3 (pl) | Probiotyki wpływające na metabolizm tłuszczu i otyłość | |
| GB2465677B (en) | Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes | |
| GB2439393B (en) | Cannabinoids for use in the treatment of neuropathic pain | |
| IL197568A0 (en) | Treating pain, diabetes, and disorders of lipid metabolism | |
| EP2229209A4 (en) | IV CATHETER WITH ONLINE VALVE AND ASSOCIATED METHODS | |
| IL208518A0 (en) | Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions | |
| EP2317845A4 (en) | METHOD FOR TREATING AN OVERWEIGHT OR FATABLE PERSON | |
| IL205730A0 (en) | Methods for treating obesity and obesity related diseases and disorders | |
| PL2514436T3 (pl) | IL-22 do zastosowania w leczeniu schorzeń drobnoustrojowych | |
| PL2254870T3 (pl) | Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CX3CR1 | |
| ZA201101213B (en) | Compositions and methods for treating disorders associated with overweight animals | |
| EP2142664A4 (en) | ESTIMATION AND BIOLOGICAL CONSEQUENCES OF OXIDATIVE METABOLISM | |
| GB0619860D0 (en) | Treatment of insulin resistance and disorders associated therewith | |
| IL218096A0 (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| EP2049899A4 (en) | METHOD FOR THE PREVENTION AND TREATMENT OF DISEASES | |
| IL207278A0 (en) | 1 - benzyl - 3 - hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp - 1, and cx3cr1 | |
| PL2645878T3 (pl) | Zapobieganie lub leczenie nadwagi i otyłości u pacjentów z cukrzycą typu 2 | |
| IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
| EP1987826A4 (en) | MEDICAMENT AND FUNCTIONAL FOOD TO COMBAT OR PREVENT JUCKREIZ AND IGNITION | |
| PT2475361T (pt) | Derivados de benzenopropanamidas substituídas em n, para serem utilizadas no tratamento de dor e de inflamação | |
| WO2011028881A9 (en) | Methods and implants for inducing satiety in the treatment of obesity | |
| ZA200904755B (en) | Use of epothilones in the treatment of osteoporosis and related diseases |